Frequency of heparin-induced thrombocytopenia in critical care patients

Pharmacotherapy

Volumn 23, Issue 6, 2003, Pages 745-753

  Verma, Arun K ^a   Levine, Marc ^a,b   Shalansky, Stephen J ^a,c   Carter, Cedric J ^d   Kelton, John G ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; AGED; COHORT ANALYSIS; CORONARY CARE UNIT; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARIN PLATELET FACTOR 4 ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; SEROTONIN RELEASE ASSAY; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; ANTICOAGULANTS; APACHE; CRITICAL CARE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; INCIDENCE; MALE; PLATELET COUNT; PROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 0038689143     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.6.745.32188     Document Type: Review

References (32)

1. Bogdonoff DL, Williams ME, Stone DJ. Thrombocytopenia in the critically ill patient. J Crit Care 1990;5:186-205.
2. Bauer TL, Arepally G, Konkle BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242-6.
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998;79:1-7.
4. Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-8.
5. Rao AK, White GC, Sherman L, Colman R, Lan G, Ball AP. Low incidence of thrombocytopenia with porcine mucosal heparin. A prospective multicenter study. Arch Intern Med 1989;149:1285-8.
6. Pouplard C, May MA, Iochmann S, et al. Antibodies to platelet factor-4 after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight-heparin: clinical implications for heparin-induced thrombocytopenia. Circulation 1999;99:2530-6.
7. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
8. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest 1993;104:1243-7.
9. Bonfiglio MF, Traeger SM, Kier KL, Martin BR, Hulisz DT, Verbeck SR. Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients. Ann Pharmacother 1995;29:835-42.
10. Hanes SD, Quarles DA, Boucher BA. Incidence and risk factors of thrombocytopenia in critically ill trauma patients. Ann Pharmacother 1997;31:285-9.
11. Shalansky SJ, Verma AK, Levine M, Spinelli JJ, Dodek PM. Prospective analysis of risk markers for thrombocytopenia in critical care patients. Pharmacotherapy 2002;22:803-13.
12. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002;30:1765-71.
13. Pouplard C, Iochmann S, Renard B, et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 2001;97:3300-2.
14. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993;69:344-50.
15. Warkentin TE, Greinacher A. Laboratory testing for heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia, 2nd ed. New York: Marcel Dekker, 2001:231-69.
16. Morewood GH. Uncomplicated heparinization for cardiopulmonary bypass in a patient with antiheparin antibodies. J Cardiothorac Vasc Anesth 2000;14:309-11.
17. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991;66:734-6.
18. Stewart ME, Etches MW, Boshkov LK, Gordon PA. Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometry. Br J Haematol 1995;91:173-7.
19. 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995;104:648-54.
20. Puckett CD. The educational annotation of ICD-9-CM. Reno, NV: Channel Publishing, 1998.
21. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001;344:1286-92.
22. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia, 2nd ed. New York: Marcel Dekker, 2001:43-86.
23. Greinacher A. Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 1995;21:106-16.
24. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67:27-30.
25. Pagano M, Gauvreau K. Principles of biostatistics. Belmont, CA: Wadsworth Publishing, 1993.
26. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999;111:700-6.
27. Lee DH, Warkentin TE. Frequency of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia, 2nd ed. New York: Marcel Dekker, 2001:87-121.
28. Amiral J, Peynaud-Degayle E, Wolf M. Generation of antibodies to heparin-PF4 complexes without thrombo-cytopenia in patients treated with unfractionated or low-molecular-weight heparin. Am J Hematol 1996;52:90-5.
29. Bachelot-Loza C, Saffroy R, Lasne D, Chatellier G, Aiach M, Rendu F. Importance of the cgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis. Thromb Haemost 1998;79:523-8.
30. Williams WJ. Classification and clinical manifestations of disorders of hemostasis. In: Beutler E, Lichtricn MA, Coller BS, Kipps TJ, eds. Williams' hematology, 5th ed. Toronto: McGraw-Hill, 1995:1276-81.
31. Ansell J, Slepchuk N, Kumar R, Lopez A, Southard L, Deykin D. Heparin induced thrombocytopenia: a prospective study. Thromb Haemost 1980;43:61-5.
32. Powers PJ, Kelton JG, Carter CJ. Studies on the frequency of heparin-associated thrombocytopenia. Thromb Res 1984; 33:439-43.